The aim of the present work is the synthesis and characterization of polymer materials showing good adhesion, drug loading, and delivery properties, for potential cardiovascular application. In particular, poly(methylmethacrylate-co-acrylic acid) copolymers are prepared in different compositions by a radical polymerization and investigated as potential materials to coat metallic stents and to carry out a local drug release. Films obtained by dissolving the copolymer in an appropriate organic solvent (also loaded with an anti-restenosis drug, such as tacrolimus) are investigated: physicochemical properties, adhesiveness to metallic stent material, and kinetics of drug release in physiological environment are studied.
Libby, P. ( 2001) In: Braunwald, E., Zipes, D.P. and Libby, P. (eds), The Vascular Biology of Atherosclerosis, Chapter 30, In: Heart Disease: A Textbook of Cardiovascular Medicine , pp. 995-1009, Harcourt, Philadelphia.
2.
Chambless, L.E. , Heiss, G., Folsom, A.R., Rosamond, W., Szklo, M. and Sharrett, A.R. (1997). Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993, American Journal of Epidemiology, 146: 483-494.
3.
Kathuria, Y.P. (2006). The Potential of Biocompatible Metallic Stents and Preventing Restenosis, Material Science and Engineering A, 417: 40-48.
4.
Suwaidi, J.A. , Berger, P.B. and Holmes, D.R. (2000). Coronary Artery Stents , JAMA, 284: 1828-1836.
5.
Etave, F., Finet, G., Boivin, M. and Boyer J. ( 2001). Mechanical Properties of Coronary Stents Determined by using Finite Element Analysis, Journal of Biomechanics, 34: 1065-1075.
6.
Migliavacca, F., Petrini, L., Colombo, M., Auricchio, F. and Pietrabissa , R. (2002). Mechanical Behavior of Coronary Stents Investigated through the Finite Element Method, Journal of Biomechanics, 35: 803-811.
7.
El Ashmaoui, A., Do, D.D. and Triller, J. (1991). Angioplasty of the Terminal Aorta: Follow Up of 20 Patients Treated by PTA or PTA with Stents, European Journal of Radiology, 13: 113-117.
8.
Hill, R., Bagust, A., Bakhai, A., Dickson, R., Dundar, Y. and Haycox, A. ( 2004). Coronary Artery Stents and Appraisal of Drug-eluting Stents: A Rapid Systematic Review and Economic Evaluation, Health Technology Assessment, 8: 1-256.
9.
Dumoulin, C. and Cochelin, B. (2000). Mechanical Behaviour Modelling of Balloon-expandable Stents, Journal of Biomechanics , 33: 1461-1470.
10.
Burt, H.M. and Hunter, W.L. ( 2006). Drug-eluting Stents: An Innovative Multidisciplinary Drug Delivery Platform, Advanced Drug Delivery Review, 58: 350-357.
11.
Scott, N.A. (2006). Restenosis Following Implantation of Bare Metal Coronary Stents: Pathophysiology and Pathways Involved in the Vascular Response to Injury, Advanced Drug Delivery Review , 58: 358-376.
12.
Fattori, R. and Piva, T. (2003). Drug-eluting Stents in Vascular Intervention, The Lancet, 361: 247-249.
13.
Nobuyoshi, M. , Kimura, T., Ohishi, H., Horiuchi, H., Nosaka, H., Hamasaki, N., Yokoi, H. and Kim, K. (1991). Restenosis after Percutaneous Transluminal Coronary Angioplasty: Pathologic Observations in 20 Patients , Journal of the American College of Cardiology, 17: 433-439.
14.
Babapulle, M.N. and Eisenberg, M.J. (2002). Coated Stents for the Prevention of Restenosis: Part I, Circulation, 106: 2734-2740.
15.
D’Alessandro, D., Neri, E., Moscato, S., Dolfi, A., Bartolozzi, C., Calderazzi, A. and Bianchi, F. (2006). Immediate Structural Changes of Porcine Renal Arteries after Angioplasty: A Histological and Morphometric Study, Micron, 37: 255-261.
16.
Van der Hoeven, B.L., Pires, N.M.M., Warda, H.M., Oemrawsingh, P.V., van Vlijmen, B.J.M., Quax, P.H.A., Schalij, M.J., van der Wall , E.E. and Jukema J.W. (2005). Drug-eluting Stents: Results, Promises and Problems, Interventional Journal of Cardiology, 99: 9-17.
17.
Kornowski, R. , Hong, M.K., Tio, F., Bramwell, O., Wu, H. and Leon, M.B. (1998). In-stent Restenosis: Contributions of Inflammatory Responses and Arterial Injury to Neointimal Hyperplasia, Journal of the American College of Cardiology , 31: 224-230.
18.
Kamath, K.R. , Barry, J.J. and Miller, K.M. (2006). The TaxusTM Drug-eluting Stent: A New Paradigm in Controlled Drug Delivery, Advanced Drug Delivery Reviews, 58: 412-436.
19.
Sullivan, T. , Ainsworth, S., Langan, E., Taylor, S., Snyder, B., Cull, D., Youkey, J. and Laberge, M. (2002). Effect of Endovascular Stent Strut Geometry on Vascular Injury, Myointimal Hyperplasia, and Restenosis , Journal of Vascular Surgery, 36: 143-149.
20.
Hara, H., Nakamura, M., Palmaz, J.C. and Schwartz, R.S. ( 2006). Role of Stent Design and Coatings on Restenosis and Thrombosis , Advanced Drug Delivery Review, 58: 377-386.
21.
Berry, J.L. , Moore, J.E., Newman, V.S. and Routh, W.D. (1997). In Vitro Flow Visualization in Stented Arterial Segments, Journal of Vascular Investigation , 3: 63-68.
22.
Frank, A.O. , Walsh, P.W. and Moore, J.E. (2002). Computational Fluid Dynamics and Stent Design, Artificial Organs, 26: 614-625.
23.
Berry, J.L. , Santamarina, A., Moore, J.E., Roychowhury, S. and Routh, W.D. (2000). Experimental and Computational Flow Evaluation of Coronary Stents, Annals of Biomedical Engineering , 28: 386-398.
24.
Smith, E.J. and Rothman, M.T. (2003). Antiproliferative Coatings for the Treatment of Coronary Heart Disease: What are the Targets and Which are the Tools? Journal of Interventional Cardiology, 16: 475-483.
25.
Salam, A.M. , Suwaidi, J.A. and Holmes, D.R. (2006). Drug-Eluting Coronary Stents, Current Problems in Cardiology, 31: 8-119.
26.
Burke, S.E. , Kuntz, R.E. and Schwartz, L.B. (2006). Zotarolimus (ABT-578) Eluting Stents, Advanced Drug Delivery Review, 58: 437-446.
27.
Moses, J.W. , Leon, M.B., Popma, J.J., Fitzgerald, P.J., Holmes, D.R., O’Shaughnessy , C., Caputo, R.P., Kereiakes, D.J., Williams, D.O., Teirstein, P.S., Jaeger, J.L. and Kuntz, R.E. (2003). Sirolimus-Eluting Stents Versus Standard Stents in Patients with Stenosis in a Native Coronary Artery, New England Journal of Medicine , 349: 1315-1323.
28.
Morice, M.C., Serruys, P.W., Sousa, J.E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., Molnar, F. and Falotico, R. ( 2002). A Randomized Comparison of a Sirolimus-eluting Stent with a Standard Stent for Coronary Revascularization, New England Journal of Medicine, 346: 1773-1780.
29.
Grube, E. and Buellesfeld L. ( 2002). Initial Experience with Paclitaxel-coated Stents, Journal of Interventional Cardiology, 15: 471-476.
30.
Stone, G.W., Ellis, S.G., Cox, D.A., Hermiller, J., O’Shaughnessy, C., Mann, J.T., Turco, M., Caputo, R., Bergin, P. and Greenberg, J. ( 2004). A Polymer-based, Paclitaxel-eluting Stent in Patients with Coronary Artery Disease, New England Journal of Medicine , 350: 221-231.
31.
Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H. and Imanaka H. ( 1987). FK-506, a Novel Immunosuppressant Isolated from a Streptomyces . I. Fermentation, Isolation, and Physico-chemical and Biological Characteristics, Journal of Antibiotics, 40: 1249-1255.
32.
Pritchard, D. (2005). Sourcing a Chemical Succession for Cyclosporine from Parasites and Human Pathogens, Drug Discovery Today, 10: 688-691.
33.
Yoneyama, T. , Ishihara, K., Nakabayashi, N., Ito, M. and Mishima, Y. (1998). Short-term in vivo Evaluation of Small-Diameter Vascular Prosthesis Composed of Segmented Poly(etherurethane) 2-Methacryloyloxyethyl Phosphorylcholine Polymer Blend, Journal of Biomedical Materials Research, 43: 15-20.
34.
Yoneyama, T. , Sugihara, K., Ishihara, K., Iwasaki, Y. and Nakabayashi , N. (2002). The Vascular Prosthesis without Pseudointima Prepared by Anti thrombogenic Phospholipid Polymer, Biomaterials, 23: 1455-1459.
35.
Iwasaki, Y. and Ishihara, K. (2005). Phosphorylcholine-containing Polymers for Biomedical Applications, Analytical and Bioanalytical Chemistry, 381: 534-546.
36.
Ishihara, K. and Iwasaki, Y. (2000). Biocompatible Elastomers Composed of Segmented Polyurethane and 2-methacryloyloxyethyl Phosphorylcholine Polymer, Polymers for Advanced Technology, 11: 626-634.
37.
Iwasaki, Y. , Nakabayashi, N. and Ishihara, K. (2003). in vitro and ex vivo Blood Compatibility Study of 2-methacryloyloxyethyl Phosphorylcholine (MPC) Copolymer-coated Hemodialysis Hollow Fibers, Journal of Artificial Organs, 6: 260-266.
38.
Ishihara, K. , Fukumoto, K., Iwasaki, Y. and Nakabayashi , N. (1999). Modification of Polysulfone with Phospholipid Polymer for Improvement of the Blood Compatibility. Part 2. Protein Adsorption and Platelet Adhesion, Biomaterials, 20: 1553-1559.
39.
Ishihara, K. , Hanyuda, H. and Nakabayashi , N. (1995). Synthesis of Phospholipids Polymers having a Urethane Bond in the Side Chain as Coating Material on Segmented Polyurethane and their Platelet Adhesionresistant Properties, Biomaterials, 16: 873-879.
40.
Iwasaki, Y. , Mikami, A., Kurita, K., Yui, N., Ishihara, K. and Nakabayashi , N. (1997). Reduction of Surface-Induced Platelet Activation on Phospholipids Polymer , Journal of Biomedical Materials Research, 36: 508-515.
41.
Chen, C.Y., Ofenloch, J.C., Yianni, Y.P., Hanson, S.R. and Lumsden, A.B. ( 1998). Phosphorylcholine Coating of ePTFE Reduces Platelet Deposition and Neointimal Hyperplasia in Arteriovenous Grafts, Journal of Surgical Research, 77: 119-125.
42.
Chen, C.Y., Lumsden, A.B., Ofenloch, J.C., Noe, B., Campbell, E.J. and Stratford, P.W. ( 1997). Phosphorylcholine Coating of ePTFE Grafts Reduces Neointimal Hyperplasia in Canine Model, Annals of Vascular Surgery, 11: 74-79.
43.
Whelan, D.M., van der Giessen, W.J., Krabbendam, S.C., van Vliet, E.A., Verdouw, P.D. and Serruys, P.W. ( 2000). Biocompatibility of Phosphorylcholine Coated Stents in Normal Porcine Coronary Arteries, Heart, 83: 338-345.
44.
Lewis, A.L., Tolhurst, L.A. and Stratford, P.W. ( 2002). Analysis of a Phosphorylcholine-based Polymer Coating on a Coronary Stent Pre- and Post-Implantation, Biomaterials , 23: 1697-1706.
45.
Van der Giessen, W.J., Lincoff, A.M., Schwartz, R.S., van Beusekom , H.M.M., Serruys, P.W., Holmes, D.R., Ellis, S.G. and Topol, E.J. (1996). Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries, Circulation, 94: 1690-1697.
46.
Vert, M. ( 2007). Polymeric Biomaterials: Strategies of the Past Vs. Strategies of the Future, Progress in Polymer Science, 32: 755-761.
47.
Stamatialis, D.F., Papenburg, B.J., Gironés , M., Saiful, S., Bettahalli, S.N.M., Schmitmeier, S. and Wessling, M. (2008). Medical Applications of Membranes: Drug Delivery, Artificial Organs and Tissue Engineering, Journal of Membrane Science, 308: 1-34.
48.
Labarre, D. , Jozefowicz, M. and Boffa, M.C. (2004). Properties of Heparin-poly (methyl methacrylate) Copolymers, Journal of Biomedical Materials Research, 11: 283-295.
49.
Bär, F.W., van der Veen , F.H., Benzina, A., Habets, J. and Koole, L.H. (2000). New Biocompatible Polymer Surface Coating for Stents Results in a Low Neointimal Response, Journal of Biomedical Materials Research, 52: 193-198.
50.
Yazdani-Pedram, M., Retuert, J. and Quijada, R. (2000). Hydrogels based on Modified Chitosan, 1 Synthesis and Swelling Behavior of Poly(acrylic acid) Grafted Chitosan, Macromolecular Chemistry and Physics, 201: 923-930.
51.
Huang, M., Jin, X., Li, Y. and Fang, Y. ( 2006). Syntheses and Characterization of Novel pH-sensitive Graft Copolymers of Maleoylchitosan and Poly(acrylic acid), Reactive & Functional Polymers, 66: 1041-1046.
52.
Bysell, H., Hansson, P. and Malmsten, M. ( 2008). Transport of Poly-L-lysine into Oppositely Charged Poly(acrylic acid) Microgels and its Effect on Gel Deswelling, Journal of Colloid and Interface Science, 323: 60-69.
53.
Bavaresco, V.P., Zavaglia, C.A.C., Reis, M.C. and Gomes, J.R. (2008). Study on the Tribological Properties of pHEMA Hydrogels for use in Artificial Articular Cartilage, Wear, 265: 269-277.
54.
Malmonge, S.M. , Zavaglia, C.A.C. and Belangero , W.D. (2000). Biomechanical and Histological Evaluation of Hydrogel Implants in Articular Cartilage, Brazilian Journal of Medical and Biological Research , 33: 307-312.
55.
Verhoeven, M.L.P.M. , Driessen, A.A.G., Paul, A.J., Brown, A., Canry, J.C. and Hendriks, M. (2004). DSIMS Characterization of a Drug-containing Polymer-coated Cardiovascular Stent, Journal of Controlled Release, 96: 113-121.
56.
Suzuki, T., Kopia, G., Hayashi, S., Bailey, L.R., Llanos, G., Wilensky, R., Klugherz, B.D., Papandreou, G., Narayan, P., Leon, M.B., Yeung, A.C., Tio, F., Tsao, P.S., Falotico, R. and Carter, A.J. ( 2001). Stent-based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model, Circulation, 104: 1188-1193.
57.
Westedt, U., Wittmar, M., Hellwig, M., Hanefeld, P., Greiner, A., Schaper, A.K. and Kissel, T. ( 2006). Paclitaxel Releasing Films Consisting of Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their Potential as Biodegradable Stent Coatings, Journal of Controlled Release, 111: 235-246.
58.
Bar, F. , Veen, F.V.D. and Benzina , A.J. (2000). DNA Commission of the International Society for Forensic Genetics: Guidelines for Mitochondrial DNA Typing, Journal of Biomedical Material Research, 52: 193-196.
59.
Cho, J.C. , Cheng, G., Feng, D., Faust, R., Richard, R., Schwarz, M., Chan, K. and Boden, M. (2007). Synthesis, Characterization, Properties, and Drug Release of Poly(alkyl methacrylate-b-isobutylene-b-alkyl methacrylate)Biomacromolecules, 8: 2336-2336.
60.
D’Acunto, M. (2006). Nanotribology and Biomaterials: New Challenges for Atomic Force Microscopy, Chapter 1, In: Kimberly S. Gehar, (ed.), Nanophysics, Nanoclusters and Nanodevices, Nova Science.
61.
Acharya, G. and Park, K. (2006). Mechanisms of Controlled Drug Release from Drug-eluting Stents, Advanced Drug Delivery Review, 58: 387-401.
62.
Kuksal, A., Tiwary, A.K., Jain, N.K. and Jain, S. ( 2006). Formulation and in vitro, in vivo Evaluation of Extended-release Matrix Tablet of Zidovudine: Influence of Combination of Hydrophilic and Hydrophobic Matrix Formers, AAPS PharmSciTech, 7: E1.
63.
Hastings, G.W. and Ducheyne, P. (1984). Macromolecular Biomaterials , CRC Press, Boca Raton, Florida , USA.
64.
Packham, D.E. (1996). Work of Adhesion: Contact Angles and Contact Mechanics, International Journal of Adhesion & Adhesives, 16: 121-128.
65.
Reza, M.S., Quadir, M.A. and Haider, S.S. ( 2003). Comparative Evaluation of Plastic, Hydrophilic and Hydrophobic Polymers as Matrices for Controlled Release Drug Delivery, Journal of Pharmacy and Pharmaceutical Sciences, 6: 282-291.
66.
Riccardi, A. , Servidei, T., Tornesello, A., Puggioni, P., Mastrangelo, S. and Rumi, C. (1995). Cytotoxicity of Paclitaxel and Docetaxel in Human Neuroblastoma Cell Lines, European Journal of Cancer, 31A: 494-499.
67.
Rowinsky, E.K. and Donehower, R.C. (1995). Paclitaxel (Taxol) , New England Journal of Medicine, 332: 1004-1014.
